Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
57
BCLI Quote, Financials, Valuation and Earnings
Last price:
$0.67
Seasonality move
:
24.38%
Day range:
$0.56 - $0.68
52-week range:
$0.52 - $2.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
114.1K
Avg. volume:
22.9K
1-year change:
-73.13%
Market cap:
$7.4M
Revenue:
--
EPS (TTM):
-$1.46
Brainstorm Cell Therapeutics, Inc. SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/14/2024 | 10-Q | 10-Q filing on 05/14/2024 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
11/14/2023 | 10-Q | 10-Q filing on 11/14/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/14/2023 | 10-Q | 10-Q filing on 08/14/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/15/2023 | 10-Q | 10-Q filing on 05/15/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
11/14/2022 | 10-Q | 10-Q filing on 11/14/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/15/2022 | 10-Q | 10-Q filing on 08/15/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/16/2022 | 10-Q | 10-Q filing on 05/16/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
11/15/2021 | 10-Q | 10-Q filing on 11/15/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/05/2021 | 10-Q | 10-Q filing on 08/05/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
04/26/2021 | 10-Q | 10-Q filing on 04/26/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
02/04/2021 | 10-K | 10-K filing on 02/04/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
10/15/2020 | 10-Q | 10-Q filing on 10/15/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/05/2020 | 10-Q | 10-Q filing on 08/05/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
02/18/2020 | 10-K | 10-K filing on 02/18/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
11/14/2019 | 10-Q | 10-Q filing on 11/14/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/13/2019 | 10-Q | 10-Q filing on 08/13/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
04/01/2019 | 10-K | 10-K filing on 04/01/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
03/29/2019 | 10-K | 10-K filing on 03/29/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
10/29/2018 | 10-Q | 10-Q filing on 10/29/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
07/23/2018 | 10-Q | 10-Q filing on 07/23/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/14/2018 | 10-Q | 10-Q filing on 05/14/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
10/17/2017 | 10-Q | 10-Q filing on 10/17/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/14/2017 | 10-Q | 10-Q filing on 08/14/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/15/2017 | 10-Q | 10-Q filing on 05/15/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
03/29/2017 | 10-K | 10-K filing on 03/29/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
11/14/2016 | 10-Q | 10-Q filing on 11/14/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
08/11/2016 | 10-Q | 10-Q filing on 08/11/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics, Inc.
|
03/09/2016 | 10-K | 10-K filing on 03/09/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
78
TVTX alert for Dec 27
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
